Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders (Q34358480)

1 August 2017

5 references

25 April 2019

31 July 2019

15 December 2019

21 December 2019

1 November 2020

Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders (English)

1 reference

1 August 2017

0 references

5 references

25 April 2019

31 July 2019

15 December 2019

21 December 2019

1 November 2020

cell surface receptor

1 reference

31 July 2019

1 reference

15 December 2019

intracellular receptor

1 reference

21 December 2019

hypnotics and sedatives

1 reference

1 November 2020

Moshe Laudon

1

1 reference

1 August 2017

Anat Frydman-Marom

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

9 September 2014

6 references

International Journal of Molecular Sciences

1 August 2017

25 April 2019

31 July 2019

15 December 2019

21 December 2019

1 November 2020

6 references

1 August 2017

25 April 2019

31 July 2019

15 December 2019

21 December 2019

1 November 2020

15

1 reference

1 August 2017

issue

9

1 reference

1 August 2017

page(s)

15924-15950

1 reference

Creative Commons Attribution

1 August 2017

copyright license

5 references

25 April 2019

31 July 2019

15 December 2019

21 December 2019

1 November 2020

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Advances in the management of insomnia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Tasimelteon: first global approval

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

The association between sleep disturbances and suicidal behaviors in patients with psychiatric diagnoses: a systematic review and meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Sleep and Alzheimer disease pathology--a bidirectional relationship

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Aging, circadian rhythms and depressive disorders: a review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin and its atheroprotective effects: a review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Self-reported sleep and β-amyloid deposition in community-dwelling older adults

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Sleep disorders and depression: brief review of the literature, case report, and nonpharmacologic interventions for depression

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin in Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Sleep Fragmentation and the Risk of Incident Alzheimer's Disease and Cognitive Decline in Older Persons

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin attenuates high fat diet-induced fatty liver disease in rats

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Sleep quality and preclinical Alzheimer disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Therapeutic application of melatonin in mild cognitive impairment.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin may curtail the metabolic syndrome: studies on initial and fully established fructose-induced metabolic syndrome in rats

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

[Metabolic disorders in elderly patients with hypertension and their correction with melatonin].

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Alterations in Lipid Levels of Mitochondrial Membranes Induced by Amyloid-β: A Protective Role of Melatonin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Sleep disturbances in Alzheimer's and Parkinson's diseases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Nocturnal blood pressure, morning blood pressure surge, and cerebrovascular events

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Agomelatine: a novel antidepressant

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Sleep disorders in Parkinson disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: the MORGEN study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Agomelatine for the treatment of major depressive disorder

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Decreased slow wave sleep increases risk of developing hypertension in elderly men

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

A benefit-risk assessment of agomelatine in the treatment of major depression

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

When Parkinson's disease patients go to sleep: specific sleep disturbances related to Parkinson's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin in autism spectrum disorders: a systematic review and meta-analysis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Cross-sectional associations between measures of sleep and markers of glucose metabolism among subjects with and without diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Sleep Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Diabetes and sleep: A complex cause-and-effect relationship

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Genetic variants in MTNR1B affecting insulin secretion

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin: a multitasking molecule

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin MT1 and MT2 receptor expression in Parkinson's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Urinary melatonin and risk of incident hypertension among young women

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Insomnia and sleep duration as mediators of the relationship between depression and hypertension incidence

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Agomelatine, a melatonin agonist with antidepressant properties

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Ramelteon: a review of its therapeutic potential in sleep disorders

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Ramelteon for insomnia symptoms in a community sample of adults with generalized anxiety disorder: an open label study.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Comorbid insomnia: current directions and future challenges.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Variants in MTNR1B influence fasting glucose levels

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Agomelatine treatment of major depressive disorder

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

A review of ramelteon in the treatment of sleep disorders

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Association between depressive symptoms and sleep disturbances in community-dwelling older men

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Insomnia in patients with neurodegenerative conditions.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Insomnia and comorbid psychiatric disorders

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin, endocrine pancreas and diabetes.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Abnormal melatonin synthesis in autism spectrum disorders

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Sleep and sleep disturbances: biological basis and clinical implications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Sleep disturbances and excessive daytime sleepiness in Parkinson disease: an overview.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Sleep-anticipating effects of melatonin in the human brain.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Role of melatonin in Alzheimer-like neurodegeneration

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

The role of ML-23 and other melatonin analogues in the treatment and management of Parkinson's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Metabolic effects of melatonin on oxidative stress and diabetes mellitus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Sleep issues in Parkinson's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Nonmotor complications in Parkinson's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Insomnia in neurological diseases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

A single blind, placebo controlled, across groups dose escalation study of the safety, tolerability, pharmacokinetics and pharmacodynamics of the melatonin analog beta-methyl-6-chloromelatonin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Insomnia: epidemiology, characteristics, and consequences

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Role of melatonin in the regulation of human circadian rhythms and sleep

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Place of chronic insomnia in the course of depressive and anxiety disorders

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin and the cardiovascular system.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Sleep disturbances and mood disorders: an epidemiologic perspective

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Circadian rhythm sleep disorders: pathophysiology and potential approaches to management

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Diabetes--a common, growing, serious, costly, and potentially preventable public health problem.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin Improves Sleep Quality of Patients With Chronic Schizophrenia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Use of slow-release melatonin in treatment-resistant depression

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Nocturnal melatonin secretion and its modification by treatment in patients with sleep disorders

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin for the Treatment of Sleep Disturbances in Major Depressive Disorder

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Sleep disorders and melatonin rhythms in elderly people

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Changes in gamma-aminobutyric acid high affinity binding to cerebral cortex membranes after pinealectomy or melatonin administration to rats

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Circadian rhythms of melatonin and cortisol in aging.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Serotonin and antidepressant drugs antagonize melatonin-induced behavioural changes after injection into the nucleus accumbens of rats

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Association of sleep-wake habits in older people with changes in output of circadian pacemaker

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Is the pineal gland involved in the pathogenesis of endometrial carcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Proceedings: The effect of melatonin on pinealectomy-induced hypertension in the rat

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Effect of pinealectomy on arterial blood pressure and food and water intake in the rat

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

DSM-5 sleep-wake disorders classification: overview for use in clinical practice

6 July 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Insomnia as a risk factor for ill health: results from the large population-based prospective HUNT Study in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

An investigation into sleep characteristics of children with autism and Asperger's Disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Prolonged-release melatonin for children with neurodevelopmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Does agomelatine have a place in the treatment of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

The efficacy of agomelatine in previously-treated depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

The bidirectional association between depression and insomnia: the HUNT study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

A bidirectional relationship between anxiety and depression, and insomnia? A prospective study in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Associations of nonrestorative sleep with insomnia, depression, and daytime function

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Corticosterone attenuates the antidepressant-like effects elicited by melatonin in the forced swim test in both male and female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-D-aspartate receptors and the L-arginine-nitric oxide pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Melatonin increases in vivo GABA accumulation in rat hypothalamus, cerebellum, cerebral cortex and pineal gland

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Antidepressant action of agomelatine (S 20098) in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Melatonin modulates [3h]serotonin release in the rat hippocampus: effects of circadian rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

A double-blind, randomized, placebo-controlled trial of adjunctive ramelteon for the treatment of insomnia and mood stability in patients with euthymic bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Poor sleep quality impairs cognitive performance in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Sleep disturbances in Parkinson's disease with emphasis on rapid eye movement sleep behavior disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Amyloid-beta neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3beta, tau and neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Melatonin protects against amyloid-β-induced impairments of hippocampal LTP and spatial learning in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Melatonin synergizes with low doses of L-DOPA to improve dendritic spine density in the mouse striatum in experimental Parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Protective effect of melatonin in a chronic experimental model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Study of circadian melatonin secretion pattern at different stages of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Melatonin for sleep disturbances in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Use of ramelteon for the treatment of secondary REM sleep behavior disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Myocardial ischemia-reperfusion in rats: reduction of infarct size by either supplemental physiological or pharmacological doses of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Potentially beneficial cardiovascular effects of melatonin administration in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Understanding sleep in persons with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Psychological distress and risk of pre-diabetes and Type 2 diabetes in a prospective study of Swedish middle-aged men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Melatonin prevents the development of the metabolic syndrome in male rats exposed to different light/dark regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

A new strategy of treatment of insomnia in the field of cardiology--potential of ramelteon

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin-insulin interactions in patients with metabolic syndrome

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Major depressive disorder, sleep EEG and agomelatine: an open-label study

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin in schizophrenic outpatients with insomnia: a double-blind, placebo-controlled study

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Impaired nocturnal melatonin secretion in non-dipper hypertensive patients.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin is protective against MPTP-induced striatal and hippocampal lesions.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin agonists modulate 5-HT2A receptor-mediated neurotransmission: behavioral and biochemical studies in the rat.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200764

Melatonin Reduces Night Blood Pressure in Patients with Nocturnal Hypertension

27 October 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS150915924

Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation

21 January 2018

1 reference

12 December 2020

Ramelteon for the treatment of delirium in elderly patients: a consecutive case series study

1 reference

12 December 2020

Time-Dependent Effect of Melatonin on Glutamic Acid Decarboxylase Activity and CI Influx in Rat Hypothalamus

1 reference

12 December 2020

[Sleep disorders in Parkinson's disease without dementia: a comparative randomized controlled study of melatonin and clonazepam]

1 reference

12 December 2020

The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT2C receptors

1 reference

12 December 2020

Quantitative assessment of Parkinson's disease deficits

1 reference

12 December 2020

Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men

1 reference

12 December 2020

Abnormal circadian rhythm of melatonin in diabetic autonomic neuropathy

1 reference

12 December 2020

Decreased melatonin synthesis in patients with coronary artery disease

1 reference

12 December 2020

Effects of chronic melatonin administration on GABA and diazepam binding in rat brain

1 reference

12 December 2020

The pharmacologic rationale for the clinical use of antidepressants.

1 reference

12 December 2020

Corticosterone regulation of 5-HT2A receptor-mediated behaviors: attenuation by melatonin

1 reference

12 December 2020

Sleep disorders in Parkinson's disease

1 reference

12 December 2020

US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008

1 reference

12 December 2020

Impaired nocturnal secretion of melatonin in coronary heart disease

1 reference

12 December 2020

Influences of melatonin administration on the circulation of women

1 reference

12 December 2020

The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension

1 reference

12 December 2020

The effect of continuous light exposure of rats on cardiac response to ischemia-reperfusion and NO-synthase activity

1 reference

12 December 2020

Identifiers

DOI

10.3390/IJMS150915924

1 reference

release_nto7ouogs5ccpon42wm4d2qtxu

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nto7ouogs5ccpon42wm4d2qtxu

24 November 2022

mapped directly with Wikidata item

PMC publication ID

4200764

1 reference

1 August 2017

1 reference